Variations of proline-rich kinase Pyk2 expression correlate with prostate cancer progression. - Wikidata - wikimedia - TriplyDB

Variations of proline-rich kinase Pyk2 expression correlate with prostate cancer progression.

Variations of proline-rich kinase Pyk2 expression correlate with prostate cancer progression.

http://www.wikidata.org/entity/Q32005910

about

Leupaxin, a novel coactivator of the androgen receptor, is expressed in prostate cancer and plays a role in adhesion and invasion of prostate carcinoma cells The role of proline rich tyrosine kinase 2 (Pyk2) on cisplatin resistance in hepatocellular carcinoma Suppression of androgen receptor transactivation by Pyk2 via interaction and phosphorylation of the ARA55 coregulator.HCMV pUS28 initiates pro-migratory signaling via activation of Pyk2 kinase Understanding the roles of FAK in cancer: inhibitors, genetic models, and new insights Nonreceptor tyrosine kinases in prostate cancer.Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.Proline-rich tyrosine kinase 2 and its phosphorylated form pY881 are novel prognostic markers for non-small-cell lung cancer progression and patients' overall survival.Convergent Effects of Resveratrol and PYK2 on Prostate Cells.CaMKK2: a novel target for shaping the androgen-regulated tumor ecosystem.Effects of Resveratrol on p66Shc phosphorylation in cultured prostate cells.Biochemical Changes in the Niche Following Tumor Cell Invasion.The role of SRC family kinases in prostate cancer.The significance of proline-rich tyrosine kinase2 (Pyk2) on hepatocellular carcinoma progression and recurrence.Interaction of Pyk2 and PTP-PEST with leupaxin in prostate cancer cells.Loss of proline-rich tyrosine kinase 2 function induces spreading and motility of epithelial prostate cells.EPN: a novel epithelial cell line derived from human prostate tissue.Overexpression of chromatin assembly factor-1 (CAF-1) p60 is predictive of adverse behaviour of prostatic cancer.High expression of proline-rich tyrosine kinase 2 is associated with poor survival of hepatocellular carcinoma via regulating phosphatidylinositol 3-kinase/AKT pathway.

P2860

Q24308733-AF69B35E-457F-4E01-8B21-D6FFC77B11F5 Q28477884-F173B936-E356-4F07-87EB-35755A6C7B81 Q30816464-1144D571-51B5-4B11-8FA3-5EE788DC51B6 Q34631652-B8C3C1FC-6724-4C70-B583-B22B1A223978 Q35009792-8DF36BF1-8C0C-49AB-ABE6-8A647A0B9914 Q36759212-8369E1A4-9E12-4886-9AC0-0DFB35F66587 Q36943119-25B3C8A9-4097-43AD-BCAD-70D7A66FF872 Q37185797-10C95718-7109-4EB3-856D-81F08895655B Q37286593-A2007306-C008-43D4-B549-86C32BDB90B6 Q38075267-304D9BE7-0716-47C3-A384-927B3030BA38 Q38780934-4476E166-6D69-49ED-A316-6F9FD026ED1C Q39041143-4D60FB88-7643-437E-A5DA-AD20303E71A0 Q40055337-B450563D-8DAB-4C77-850F-BC3702A1AFDD Q40123406-D5E510ED-CBD8-4B54-9DE2-3D112B1AC4F4 Q40165268-788F99BB-2300-44C1-8BD7-C7FD2F6B8FE4 Q40265863-7F548193-F492-468E-8EA5-37B5DC3CCDA9 Q40730255-71757A8C-85A4-48B9-B604-03E21D50D3E2 Q44112283-09C1F9C9-2F30-4424-A777-A7C76A622A96 Q54308665-6212DC4D-B0D5-4727-83E6-E47ADFFCACB0

P2860

Variations of proline-rich kinase Pyk2 expression correlate with prostate cancer progression.

http://www.wikidata.org/entity/Q32005910

description

2001 nî lūn-bûn

@nan

2001 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Variations of proline-rich kin ...... h prostate cancer progression.

@ast

Variations of proline-rich kin ...... h prostate cancer progression.

@en

type

label

Variations of proline-rich kin ...... h prostate cancer progression.

@ast

Variations of proline-rich kin ...... h prostate cancer progression.

@en

prefLabel

Variations of proline-rich kin ...... h prostate cancer progression.

@ast

Variations of proline-rich kin ...... h prostate cancer progression.

@en

P1433

Q32005910-F77C1EE3-4BA1-4D1E-99D5-371C016386FB

P1476

Q32005910-D30CF957-E408-4A9C-BDB8-EAAEEC378161

P2093

Q32005910-07DB1F7E-B355-43B9-AEC0-9AD4168922C2

Q32005910-43F5FB4B-C3E7-4B39-A33D-211D14DE6DA6

Q32005910-7C1059CD-4457-4EAA-B27B-0E87FD481416

Q32005910-882946E6-3FDC-4C9A-8668-0B26D2679847

Q32005910-B7DB7760-98FA-4D64-BF6E-1BF7159350E5

Q32005910-C3D84E00-A266-48DA-A682-EB2CDA653612

Q32005910-D9469C7E-33A5-40C0-BA3B-C4B870821C23

Q32005910-E89EA998-B554-4B17-82C1-C92BCC545F74

Q32005910-EADC27B7-75C6-4FEF-9DA6-E31BEF64B66D

Q32005910-F9805A2C-C803-4A74-9B83-B63DD7EEC18A

P2860

Q32005910-0282F76B-E00D-4312-9D51-7BAC6CD64A40

Q32005910-0FE6D418-5315-44CA-9380-3CEC972DD882

Q32005910-22BDA5A8-E697-499F-AB79-AC7D1574E97D

Q32005910-2EC89BE4-1C20-434B-9C28-32E08A66F58F

Q32005910-301C4556-9307-41DD-B7E9-17D18A2ADE2E

Q32005910-3681F173-96B2-4206-ACEA-475E67855430

Q32005910-3B431426-D848-4E35-900B-228A4E38F10D

Q32005910-3D1E0307-AB2B-46A8-B563-8EB9EBB74780

Q32005910-400B9ED1-29EF-4D87-A9F7-267A68129569

Q32005910-44B6B3DC-4F7A-4D75-87D3-09CF495B75B3

P2888

Q32005910-7AF33093-E45E-4A00-B78C-0014315D02BC

P304

Q32005910-CA3486E3-2EA1-43EA-A527-BC7C8EC87826

P31

Q32005910-47E33FC6-A10F-40E3-9663-F338D29C56DB

P356

Q32005910-B6CE44D6-B4A5-48D4-95D0-FF792D42A0E0

P433

Q32005910-ADA51838-5678-49C3-88E8-2311CB9B6EF5

P478

Q32005910-8CC6C8A2-60D7-4B6A-90AF-C64BDC99E796

P577

Q32005910-A11CD4DB-10F5-4077-9428-54ADD2730A6D

P5875

Q32005910-FFF57B48-680C-4EED-AB99-34C25AC6D15D

P6179

Q32005910-3B95D231-5A8B-493C-AA0D-872D59887C94

P698

Q32005910-C5EB4AC8-56D2-4F00-A34F-299FA6D1E656

P356

LABINVEST.3780211

P1433

Laboratory Investigation

P1476

Variations of proline-rich kin ...... h prostate cancer progression.

@en

P2093

Chieffi P

http://www.w3.org/2001/XMLSchema#string

De Rosa G

http://www.w3.org/2001/XMLSchema#string

Franco R

http://www.w3.org/2001/XMLSchema#string

Imbimbo C

http://www.w3.org/2001/XMLSchema#string

Mirone V

http://www.w3.org/2001/XMLSchema#string

Palmieri A

http://www.w3.org/2001/XMLSchema#string

Picascia A

http://www.w3.org/2001/XMLSchema#string

Schlessinger J

http://www.w3.org/2001/XMLSchema#string

Staibano S

http://www.w3.org/2001/XMLSchema#string

Stanzione R

http://www.w3.org/2001/XMLSchema#string

P2860

Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions

A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation

Activation of Pyk2 by stress signals and coupling with JNK signaling pathway

pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions.

A tyrosine kinase profile of prostate carcinoma

Suppression of Pyk2 kinase and cellular activities by FIP200

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

Tyrosine kinase Pyk2 mediates G-protein-coupled receptor regulation of the Ewing sarcoma RNA-binding protein EWS

Differential regulation of Pyk2 and focal adhesion kinase (FAK). The C-terminal domain of FAK confers response to cell adhesion

Pyk2 and Src-family protein-tyrosine kinases compensate for the loss of FAK in fibronectin-stimulated signaling events but Pyk2 does not fully function to enhance FAK- cell migration.

P2888

labinvest.3780211

P304

51-59

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LABINVEST.3780211

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P577

2001-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12127479

http://www.w3.org/2001/XMLSchema#string

P6179

1009984067

http://www.w3.org/2001/XMLSchema#string

P698

11204274

http://www.w3.org/2001/XMLSchema#string